Patents by Inventor Jos van Strijp

Jos van Strijp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES AND METHODS OF USE THEREOF IN TREATMENT OF INFECTIOUS DISEASE
    Publication number: 20220332801
    Abstract: The present invention relates to antibody molecules that bind to Wall Teichoic Acid (WTA) or Capsular Polysaccharides (CP) such as Capsular Polysaccharides type 5 (CP5). The invention relates in particular to antibody molecules of the IgG isotype having a mutation in the Fc domain that enhances clustering of IgG molecules after target binding.
    Type: Application
    Filed: November 24, 2021
    Publication date: October 20, 2022
    Inventors: Annemarie KUIPERS, Kok VAN KESSEL, Frank BEURSKENS, Rob DE JONG, Kristin STRUMANE, Janine SCHUURMAN, Paul PARREN, Jos VAN STRIJP, Suzan ROOIJAKKERS
  • ANTIBODIES AND METHODS OF USE THEREOF IN TREATMENT OF INFECTIOUS DISEASE
    Publication number: 20200123237
    Abstract: The present invention relates to antibody molecules that bind to Wall Teichoic Acid (WTA) or Capsular Polysaccharides (CP) such as Capsular Polysaccharides type 5 (CP5). The invention relates in particular to antibody molecules of the IgG isotype having a mutation in the Fc domain that enhances clustering of IgG molecules after target binding.
    Type: Application
    Filed: May 17, 2017
    Publication date: April 23, 2020
    Applicant: Genmab B.V.
    Inventors: Annemarie KUIPERS, Kok van KESSEL, Frank BEURSKENS, Rob de JONG, Kristin STRUMANE, Janine SCHUURMAN, Paul PARREN, Jos van STRIJP, Suzan ROOIJAKKERS
  • VACCINE BASED ON STAPHYLOCOCCAL SUPERANTIGEN-LIKE 3 PROTEIN (SSL3)
    Publication number: 20140248273
    Abstract: The present invention relates to the field of vaccinology, especially of vaccines against Staphylococcus aureus, for both human and veterinary application. In particular the invention relates to a Staphylococcal superantigen-like 3 (SSL3) protein or its homolog, an immunogenic fragment of either protein, for use in a vaccine against S. aureus. In addition the invention relates to vaccines, methods, and medical uses of these proteins.
    Type: Application
    Filed: September 7, 2012
    Publication date: September 4, 2014
    Inventors: Jos van Strijp, Carla de Haas, Paul Vermeij, Bart Bardoel